CDH1 and breast carcinoma: Zhang et al. carried out further studies on miR-138 in breast cancer cells, and found that miR-138 overexpression was involved in EMT inhibitory events via the impairment of vimentin, N-cadherin, and Snail expression, but with activation of E-cadherin expression [96].